Influence of Asthma Status on Serotype-Specific Pneumococcal Antibody Levels

References

• . Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR–8):1–24
   Google Scholar
• . Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002;51(2):98–104
   Google Scholar
• . Talbot TR, Hartert, TV, Mitchel E, . Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082–2090
   PubMed Web of Science ®Google Scholar
• . Juhn YJ, Kita H, Yawn BP, . Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008;122(4):719–723
   PubMedGoogle Scholar
• . Centers for Disease Control and Prevention. ACIP provisional recommendations for the use of pneumococcal vaccines. Atlanta, GA: Centers for Disease Control and Prevention; 2009
   Google Scholar
• . Luo R, Mann B, Lewis WS, . Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. Embo J. 2005;24(1):34–43
   Google Scholar
• . Kaetzel CS. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev. 2005;206:83–99
   PubMed Web of Science ®Google Scholar
• . Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(1):31–44
   PubMed Web of Science ®Google Scholar
• . Juhn YJ, Kita H, Yawn BP, Boyce T, Jacobson RM. The potential mechanisms for increased risk of serious pneumococcal diseases in asthmatics. J Allergy Clin Immunol. In press
   Google Scholar
• . Sjölander A, Baldwin TM, Curtis JM, Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J Immunology. 1998;160(8):3949–3957
   PubMed Web of Science ®Google Scholar
• . Chaplin D, Zindl C, Duffy L, Atkinson T, Lai J. Clearance of Mycoplasma pneumoniae is impaired in mice with established allergic airway inflammation. J Allergy Clin Immunol. 2007;119:S132
   Google Scholar
• . Kincy-Cain T, Clements JD, Bost KL. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun. 1996;64(4):1437–1440
   PubMed Web of Science ®Google Scholar
• . Beisswenger C, Kandler K, Hess C, . Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol. 2006;177(3):1833–1837
   Google Scholar
• . van Den Broek M, Bachmann MF, Köhler G, . IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol. 2000;164(1):371–378
   Google Scholar
• . Fischer JE, Johnson JE, Kuli-Zade RK, . Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol. 1997;71(11):8672–8677
   Google Scholar
• . Romanni L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 response with acquired resistance. Infect Immun. 1991;59(12):4647–4654
   Google Scholar
• . Smart JM, Kemp AS. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy. 2002;32(5):796–802
   PubMed Web of Science ®Google Scholar
• . Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet. 2007;370(9596):1422–1431
   PubMed Web of Science ®Google Scholar
• . Khan AQ, Shen Y, Wu ZQ, Wynn TA, Snapper CM. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun. 2002;70(2):749–761
   PubMed Web of Science ®Google Scholar
• . Spindler C, Hedlund J, Jasir A, Normark BH, Ortqvist A. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Vaccine. 2008;26(43):5541–5546
   PubMed Web of Science ®Google Scholar
• . Conaty S, Watson L, Dinnes J, Waugh N. The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomized controlled trials. Vaccine. 2004;22(23–24):3214–3224
   PubMed Web of Science ®Google Scholar
• . Goldblatt D, Hussain M, Andrews N, . Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192(3):387–393
   PubMed Web of Science ®Google Scholar
• . Hanania NA, Sockrider M, Castro M, ; American Lung Association Asthma Clinical Research Centers. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol. 2004;113(4):717–724
   Google Scholar
• . Verstraeten T, Jumaan AO, Mullooly JP, ; Vaccine Safety Datalink Research Group. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics. 2003;112(2):e98–e103
   PubMed Web of Science ®Google Scholar
• . Jacob GL, Homburger HA. Simultaneous quantitative measurement of IgG antibodies to streptococcus pneumoniae serotypes by microsphere photometry. J Allergy Clin Immunol. 2004;113:S288
   Google Scholar
• . Sorensen RU, Leiva LE, Javier FC 3rd, . Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol. 1998;102(2):215–221
   PubMed Web of Science ®Google Scholar
• . Rubins JB, Janoff EN. Pneumococcal disease in the elderly: what is preventing vaccine efficacy? Drugs Aging. 2001;18(5):305–311
   Google Scholar
• . Silverstein MD, Reed CE, O'Connell EJ, . Long-term survival of a cohort of community residents with asthma. New Engl J Med. 1994;331(23):1537–1541
   PubMed Web of Science ®Google Scholar
• . Hunt LW Jr, Silverstein MD, Reed CE, . Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA. 1993;269(15):1947–1952
   PubMed Web of Science ®Google Scholar
• . Juhn YJ, Weaver A, Katusic S, Yunginger J. Mode of delivery at birth and development of asthma: a population-based cohort study. J Allergy Clin Immunol. 2005;116(3):510–516
   PubMedGoogle Scholar
• . Heaton T, Mallon D, Venaille T, Holt P. Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse? Allergy. 2003;58(3):252–256
   Google Scholar
• . Yu J, Carvalho Mda G, Beall B, Nahm MH. A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J Med Microbiol. 2008;57(pt 2):171–178
   Google Scholar
• . Lee HJ, Kang JH, Henrichsen J, . Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine. 1995;13(16):1533–1538
   Web of Science ®Google Scholar
• . Arkwright P, Patel L, Haeney MR, Ewing CI, David TJ. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine. Clin Exp Immunol. 2000;122(1):16–19
   Google Scholar
• . Grove DI, Burston TO, Wellby ML, Ford RM, Forbes IJ. Humoral and cellular immunity in asthma. J Allergy Clin Immunol. 1975;55(3):152–163
   PubMed Web of Science ®Google Scholar
• . Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassel GH. Deficient immune respone to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc. 2009;30(2):158–165
   Google Scholar
• . Yoo KH, Butterfield M, Jacobson RM, Poland GA, Juhn YJ. Assessment of humoral and cell-mediated immune response to MMR vaccine viruses among patients with asthma. Allergy Asthma Proc. In press
   Google Scholar
• . Schneider LC, Weinberg A, Boguniewicz M, . Abnormal immune response to varicella vaccine in subjects with atopic dermatitis compared to non-atopic controls. J Allergy Clin Immunol. 2008;121(2 suppl 1):S272–S273
   Google Scholar
• . Griffioen AW, Toebes EA, Rijkers GT, Claas FH, Datema G, Zegers BJ. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. Immunol Lett. 1992;32(3):265–272
   Google Scholar
• . Khan AQ, Lees A, Snapper CM. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact streptococcus pneumoniae in the presence of cognate CD4+ T cell help. J Immunol. 2004;172(1):532–539
   Google Scholar
• . Whitney CG, Farley MM, Hadler J, ; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737–1746
   PubMed Web of Science ®Google Scholar
• . Singleton RJ, Hennessy TW, Bulkow LR, . Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297(16):1784–1792
   PubMed Web of Science ®Google Scholar
• . Tsigrelis C, Tleyjeh I, Lahr B, Virk A, Baddour L. Temporal trends in invasive pneumococcal disease–a population-based study in Olmsted County, Minnesota, 1999–2006. Abstract number 933 presented at: 45th Annual Meeting of the Infectious Diseases Society of America (ISDA); San Diego, CA; October 4–7, 2007
   Google Scholar